These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23701381)

  • 1. Implications of genome-wide association studies in cancer therapeutics.
    Patel JN; McLeod HL; Innocenti F
    Br J Clin Pharmacol; 2013 Sep; 76(3):370-80. PubMed ID: 23701381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association studies of cancer: current insights and future perspectives.
    Sud A; Kinnersley B; Houlston RS
    Nat Rev Cancer; 2017 Nov; 17(11):692-704. PubMed ID: 29026206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer?
    Srinivasan S; Clements JA; Batra J
    Crit Rev Clin Lab Sci; 2016; 53(1):29-39. PubMed ID: 26398894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer pharmacogenomics: strategies and challenges.
    Wheeler HE; Maitland ML; Dolan ME; Cox NJ; Ratain MJ
    Nat Rev Genet; 2013 Jan; 14(1):23-34. PubMed ID: 23183705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study.
    Mhatre S; Wang Z; Nagrani R; Badwe R; Chiplunkar S; Mittal B; Yadav S; Zhang H; Chung CC; Patil P; Chanock S; Dikshit R; Chatterjee N; Rajaraman P
    Lancet Oncol; 2017 Apr; 18(4):535-544. PubMed ID: 28274756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons and implications from association studies and post-GWAS analyses of cervical cancer.
    Chen D; Gyllensten U
    Trends Genet; 2015 Jan; 31(1):41-54. PubMed ID: 25467628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms to predict outcome to the tyrosine kinase inhibitors gefitinib, erlotinib, sorafenib and sunitinib.
    Erdem L; Giovannetti E; Leon LG; Honeywell R; Peters GJ
    Curr Top Med Chem; 2012; 12(15):1649-59. PubMed ID: 22978339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC).
    Bolton KL; Ganda C; Berchuck A; Pharaoh PD; Gayther SA
    J Intern Med; 2012 Apr; 271(4):366-78. PubMed ID: 22443200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis.
    Uimari O; Rahmioglu N; Nyholt DR; Vincent K; Missmer SA; Becker C; Morris AP; Montgomery GW; Zondervan KT
    Hum Reprod; 2017 Apr; 32(4):780-793. PubMed ID: 28333195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of GWAS-identified lung cancer susceptibility loci with survival length in patients with small-cell lung cancer treated with platinum-based chemotherapy.
    Li D; Wei L; Xu B; Yu D; Chang J; Yuan P; Du Z; Tan W; Shen H; Wu T; Wu C; Lin D
    PLoS One; 2014; 9(11):e113574. PubMed ID: 25415319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-Wide Association Studies of Chemotherapeutic Toxicities: Genomics of Inequality.
    Mapes B; El Charif O; Al-Sawwaf S; Dolan ME
    Clin Cancer Res; 2017 Aug; 23(15):4010-4019. PubMed ID: 28442506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer.
    Gao G; Pierce BL; Olopade OI; Im HK; Huo D
    PLoS Genet; 2017 Sep; 13(9):e1006727. PubMed ID: 28957356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common variants identified in genome-wide association studies of testicular germ cell tumour: an update, biological insights and clinical application.
    Litchfield K; Shipley J; Turnbull C
    Andrology; 2015 Jan; 3(1):34-46. PubMed ID: 25598472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Analysis of Genome-Wide Association Studies: Triple Negative Breast Cancer
    Jurj MA; Buse M; Zimta AA; Paradiso A; Korban SS; Pop LA; Berindan-Neagoe I
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma.
    Magrangeas F; Kuiper R; Avet-Loiseau H; Gouraud W; Guérin-Charbonnel C; Ferrer L; Aussem A; Elghazel H; Suhard J; Sakissian H; Attal M; C Munshi N; Sonneveld P; Dumontet C; Moreau P; van Duin M; Campion L; Minvielle S
    Clin Cancer Res; 2016 Sep; 22(17):4350-4355. PubMed ID: 27060151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A colorectal cancer susceptibility new variant at 4q26 in the Spanish population identified by genome-wide association analysis.
    Real LM; Ruiz A; Gayán J; González-Pérez A; Sáez ME; Ramírez-Lorca R; Morón FJ; Velasco J; Marginet-Flinch R; Musulén E; Carrasco JM; Moreno-Rey C; Vázquez E; Chaves-Conde M; Moreno-Nogueira JA; Hidalgo-Pascual M; Ferrero-Herrero E; Castellví-Bel S; Castells A; Fernandez-Rozadilla C; Ruiz-Ponte C; Carracedo A; González B; Alonso S; Perucho M
    PLoS One; 2014; 9(6):e101178. PubMed ID: 24978480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
    Low SK; Takahashi A; Mushiroda T; Kubo M
    Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design considerations for genetic linkage and association studies.
    Nsengimana J; Bishop DT
    Methods Mol Biol; 2012; 850():237-62. PubMed ID: 22307702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
    Ishak MB; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of genomic information to optimize cancer chemotherapy.
    Innocenti F; Cox NJ; Dolan ME
    Semin Oncol; 2011 Apr; 38(2):186-95. PubMed ID: 21421109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.